Cormorant Asset Management’s Outlook Therapeutics OTLK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-788
Closed -$23K 70
2019
Q3
$23K Hold
788
﹤0.01% 68
2019
Q2
$32K Buy
+788
New +$32K ﹤0.01% 66
2018
Q1
Sell
-191
Closed -$40K 53
2017
Q4
$40K Sell
191
-3,521
-95% -$737K ﹤0.01% 46
2017
Q3
$814K Sell
3,712
-2,554
-41% -$560K 0.14% 47
2017
Q2
$1.01M Hold
6,266
0.17% 62
2017
Q1
$2.69M Buy
6,266
+1,058
+20% +$454K 0.39% 54
2016
Q4
$2.51M Sell
5,208
-1,212
-19% -$584K 0.34% 56
2016
Q3
$4.37M Hold
6,420
0.48% 54
2016
Q2
$3.49M Buy
+6,420
New +$3.49M 0.5% 52